The part of the development which has given rise to new hopes, are the reports that the AstraZeneca-backed vaccine candidate might be able to provide ‘double protection’ against the highly infectious coronavirus.

The part of the development which has given rise to new hopes, are the reports that the AstraZeneca-backed vaccine candidate might be able to provide ‘double protection’ against the highly infectious coronavirus.